Sanofi wins FDA nod for short-needle shot; J&J's Remicade meets pediatric study goals;

@FiercePharma: Pharma CEOs lost in the executive-pay shuffle. Story | Follow @FiercePharma

> Sanofi Aventis said it has won U.S. approval to market its Fluzone intradermal vaccine for adults, allowing for flu injections with a very fine needle. Report

> Johnson & Johnson said that its drug Remicade met key goals in treating pediatric patients with moderate to severe ulcerative colitis in a late-stage study. News

> The estates of a Pennsylvania couple killed in a murder-suicide two years ago has sued Pfizer, saying its stop-smoking medicine Chantix caused the rage that prompted the event. Article

> The FDA and USP have expanded their collaboration to ensure the quality of medicines by modernizing tests and standards. Report

> Somaxon Pharmaceuticals said it has filed a lawsuit against Icelandic generic drugmaker Actavis, challenging its application to make a copycat version of the insomnia drug, Silenor. Story

> GlaxoSmithKline has purchased for cancellation 450,000 of its shares for between 1302.00 pence and 1316.50 pence per share. News

> DHL Global Forwarding has opened a new center at Vienna Airport with 500 square meters of refrigerated space, expanding the range of services available to the life sciences industries. Article

Biotech News

 @FierceBiotech: How to play the game of naming new drugs. Story | Follow @FierceBiotech

 @JohnCFierce: Last summer, analysts were valuing EDT at $1B-$1.3B. Wonder what they think of the $960M deal. Follow @JohnCFierce

> Can "backyard biotechs" beat Big Pharma at the development game? Article

> FDA outlines steep hurdles, early fees for first-gen biosimilars. News 

> Developers find that Phase II hurdle is getting harder to clear. Item 

Biotech Research News

> Viruses could solve problem of hard-to-treat pancreatic cancer. Report

> Sexual orientation linked to cancer survival. News 

> Study ties chronic acetaminophen use to blood cancers. Article 

> Stem cells help create blood vessels and save life of girl. Item 

> WV's Marshall Institute means business when it comes to biotech research. Story 

> Scientists rethink serotonin, discover functions outside the brain. News 

Manufacturing News

> American Regent clears one contamination recall, starts another. Article

> Alkermes gains manufacturing strength with EDT pickup. Report

> Zacks rewards Perrigo's speedy QA turnaround. News

> Zenotech strikes over Ranbaxy/Daiichi management. Story

> NJ pharmacist murder draws Purdue reward incentive. News

> Gang poses online as carrier, steals shipments. Item

And Finally... People with a history of heart attack are at increased risk of suffering another attack or dying after even a week of taking certain types of prescription and over-the-counter painkillers, including Advil, Motrin or Voltarin, a large new study suggests. Report

Suggested Articles

Novartis is rolling out positive interim phase 3 data on Zolgensma in Europe, which could support the recent launch of the SMA gene therapy there.

The new cost-cutting goal comes on top of a €2.6 billion annual savings target the company already laid out in a revamp initiated in 2018.

As hearings continued on Capitol Hill, a congressional committee said Novartis, Amgen and Mallinckrodt used routine price hikes to meet sales targets.